FDA Inspection
Vericel CorporationVericel Corporation – FDA Inspection, Sep 25, 2024
Record Details
This FDA Inspection record concerns Vericel Corporation, with an inspection on September 25, 2024, issued by the New England District Office, covering medical devices & rad health.
View Company Profile
ID · 14fd491e-b3d9-4240-a85a-736a89e99616
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1249999
- FDA center
- Medical Devices & Rad Health
- Project area
- Compliance: Medical Devices
FDA Citations
2- 21 CFR 803.50(a)(2)Individual Report of Malfunction
- 21 CFR 820.100(a)Lack of or inadequate procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Vericel Corporation
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 12, 2026 | Not classified | New England District Office | Blood and Blood Products |
| July 21, 2023 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| May 27, 2016 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| March 19, 2014 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| September 27, 2011 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Vericel Corporation
- FDA Inspection 1322008 - 2026-06-12
- FDA Inspection 1210597 - 2023-07-21
- FDA Inspection 1006746 - 2016-05-27
- FDA Inspection 870615 - 2014-03-19
- FDA Inspection 747422 - 2011-09-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.